Cargando…

The management of talar osteochondral lesions - Current concepts

Osteochondral lesions of the talus (OLTs) are a common complication following trauma, involving both the articular cartilage and the underlying subchondral bone, with variable aetiologies and often presenting with non-specific symptoms. Diagnosis of OLTs requires a combination of clinical assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Tian, McCarthy, Helen S., Hulme, Charlotte H., Wright, Karina T., Makwana, Nilesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312263/
https://www.ncbi.nlm.nih.gov/pubmed/34337329
http://dx.doi.org/10.1016/j.jajs.2021.04.002
_version_ 1783729114376568832
author Lan, Tian
McCarthy, Helen S.
Hulme, Charlotte H.
Wright, Karina T.
Makwana, Nilesh
author_facet Lan, Tian
McCarthy, Helen S.
Hulme, Charlotte H.
Wright, Karina T.
Makwana, Nilesh
author_sort Lan, Tian
collection PubMed
description Osteochondral lesions of the talus (OLTs) are a common complication following trauma, involving both the articular cartilage and the underlying subchondral bone, with variable aetiologies and often presenting with non-specific symptoms. Diagnosis of OLTs requires a combination of clinical assessment and imaging and despite many different treatment options, there is no generalised consensus regarding which option is the most effective. Left untreated, OLTs risk progressing to osteoarthritis. Acute non-displaced OLTs can be treated non-operatively. However, OLTs refractory to non-surgical care for three to six months may be suitable for surgical care. In these cases, conservative treatments are often unsuccessful, particularly for larger and more severe defects and so the majority require surgical intervention. Although bone marrow stimulation techniques remain the “gold standard” for lesions <150 mm(2), there still requires a need for better long term clinical data and cost-benefit analyses compared with other treatment options. Biological attempts at either regenerating or replacing the articular cartilage are however demonstrating some promising results, but each with their own advantages and disadvantages. In this review, we summarise the clinical management of OLTs and present the current concepts of different treatment regimes.
format Online
Article
Text
id pubmed-8312263
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V
record_format MEDLINE/PubMed
spelling pubmed-83122632021-07-28 The management of talar osteochondral lesions - Current concepts Lan, Tian McCarthy, Helen S. Hulme, Charlotte H. Wright, Karina T. Makwana, Nilesh J Arthrosc Jt Surg Review Article Osteochondral lesions of the talus (OLTs) are a common complication following trauma, involving both the articular cartilage and the underlying subchondral bone, with variable aetiologies and often presenting with non-specific symptoms. Diagnosis of OLTs requires a combination of clinical assessment and imaging and despite many different treatment options, there is no generalised consensus regarding which option is the most effective. Left untreated, OLTs risk progressing to osteoarthritis. Acute non-displaced OLTs can be treated non-operatively. However, OLTs refractory to non-surgical care for three to six months may be suitable for surgical care. In these cases, conservative treatments are often unsuccessful, particularly for larger and more severe defects and so the majority require surgical intervention. Although bone marrow stimulation techniques remain the “gold standard” for lesions <150 mm(2), there still requires a need for better long term clinical data and cost-benefit analyses compared with other treatment options. Biological attempts at either regenerating or replacing the articular cartilage are however demonstrating some promising results, but each with their own advantages and disadvantages. In this review, we summarise the clinical management of OLTs and present the current concepts of different treatment regimes. Elsevier B.V 2021 /pmc/articles/PMC8312263/ /pubmed/34337329 http://dx.doi.org/10.1016/j.jajs.2021.04.002 Text en Crown Copyright © 2021 Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of International Society for Knowledge for Surgeons on Arthroscopy and Arthroplasty. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review Article
Lan, Tian
McCarthy, Helen S.
Hulme, Charlotte H.
Wright, Karina T.
Makwana, Nilesh
The management of talar osteochondral lesions - Current concepts
title The management of talar osteochondral lesions - Current concepts
title_full The management of talar osteochondral lesions - Current concepts
title_fullStr The management of talar osteochondral lesions - Current concepts
title_full_unstemmed The management of talar osteochondral lesions - Current concepts
title_short The management of talar osteochondral lesions - Current concepts
title_sort management of talar osteochondral lesions - current concepts
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312263/
https://www.ncbi.nlm.nih.gov/pubmed/34337329
http://dx.doi.org/10.1016/j.jajs.2021.04.002
work_keys_str_mv AT lantian themanagementoftalarosteochondrallesionscurrentconcepts
AT mccarthyhelens themanagementoftalarosteochondrallesionscurrentconcepts
AT hulmecharlotteh themanagementoftalarosteochondrallesionscurrentconcepts
AT wrightkarinat themanagementoftalarosteochondrallesionscurrentconcepts
AT makwananilesh themanagementoftalarosteochondrallesionscurrentconcepts
AT lantian managementoftalarosteochondrallesionscurrentconcepts
AT mccarthyhelens managementoftalarosteochondrallesionscurrentconcepts
AT hulmecharlotteh managementoftalarosteochondrallesionscurrentconcepts
AT wrightkarinat managementoftalarosteochondrallesionscurrentconcepts
AT makwananilesh managementoftalarosteochondrallesionscurrentconcepts